Robert J. Arciuolo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Robert J. Arciuolo has a total of 55 co-authors. Here are the top co-authors by number of shared publications:
Jane R. Zucker
Division of Disease Control, New York City Department of Health and Mental Hygiene, New York City, NY, USA; National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA
5 shared publicationsJennifer B. Rosen
New York City Department of Health and Mental Hygiene, Long Island City, NY, USA
5 shared publicationsBeth M Isaac
Bureau of Immunization, New York City Health Department , Long Island City, New York
2 shared publicationsJennifer B Rosen
Bureau of Immunization, New York City Health Department , Long Island City, New York
2 shared publications- Jennifer B. Rosen
Bureau of Immunization, New York City Department of Health and Mental Hygiene, New York, NY, USA
2 shared publications Krishika A Graham
Bureau of Immunization, New York City Health Department , Long Island City, New York
2 shared publications
Latest Publications
- 30 October 2026
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
Considerations for Assessing Measles Healthcare Facility Exposures
- 30 October 2026
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
Considerations for Assessing Measles Healthcare Facility Exposures
- 4 September 2026
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
Characterizing Measles Healthcare Facility Exposures—December 2023 Through September 2025: New York City
Background: When people develop measles (cases), healthcare facility exposures are common and result in many potentially exposed people requiring resource-intensive control measures. We summarized exposures and transmission among people exposed to measles (contacts) in healthcare settings in New York City (NYC). Methods: NYC Health Department's surveillance data of NYC contacts exposed to measles cases in any NYC healthcare facility during December 2023–September 2025 were analyzed as a retrospective descriptive study. Characteristics summarized included measles transmission, immunity status, postexposure prophylaxis (PEP) administration, facility setting, and time of measles exposure. Results: Of 2122 healthcare contacts to 28 cases, no secondary cases occurred. 1285 (60.6%) were vaccinated or had other evidence of immunity, 618 (29.1%) were adults with unknown immunity, 124 (5.8%) were not immune and received PEP, and 95 (4.5%) were not immune and did not receive PEP. Most contacts were exposed in emergency departments and/or hospital inpatient settings (1406; 66.3%). Among 1028 contacts with known time of exposure (48.4% of all contacts), 785 (76.4%) overlapped with the case in the healthcare facility, 146 (14.2%) arrived within 1 hour, and 97 (9.4%) arrived 1–2 hours after the case left or were isolated. Conclusions: Most contacts exposed to measles in NYC healthcare facilities had presumptive immunity or were adults with unknown immunity. No transmission occurred among 2122 exposed contacts, including nonimmune contacts. Given no secondary transmission and resource-intensive control measures, relying solely on time-based measles exposure definitions may be overly broad. Incorporating strategies such as facility air exchange data might better assess transmission risk.
- 4 September 2026
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
Characterizing Measles Healthcare Facility Exposures—December 2023 Through September 2025: New York City
Background: When people develop measles (cases), healthcare facility exposures are common and result in many potentially exposed people requiring resource-intensive control measures. We summarized exposures and transmission among people exposed to measles (contacts) in healthcare settings in New York City (NYC). Methods: NYC Health Department's surveillance data of NYC contacts exposed to measles cases in any NYC healthcare facility during December 2023–September 2025 were analyzed as a retrospective descriptive study. Characteristics summarized included measles transmission, immunity status, postexposure prophylaxis (PEP) administration, facility setting, and time of measles exposure. Results: Of 2122 healthcare contacts to 28 cases, no secondary cases occurred. 1285 (60.6%) were vaccinated or had other evidence of immunity, 618 (29.1%) were adults with unknown immunity, 124 (5.8%) were not immune and received PEP, and 95 (4.5%) were not immune and did not receive PEP. Most contacts were exposed in emergency departments and/or hospital inpatient settings (1406; 66.3%). Among 1028 contacts with known time of exposure (48.4% of all contacts), 785 (76.4%) overlapped with the case in the healthcare facility, 146 (14.2%) arrived within 1 hour, and 97 (9.4%) arrived 1–2 hours after the case left or were isolated. Conclusions: Most contacts exposed to measles in NYC healthcare facilities had presumptive immunity or were adults with unknown immunity. No transmission occurred among 2122 exposed contacts, including nonimmune contacts. Given no secondary transmission and resource-intensive control measures, relying solely on time-based measles exposure definitions may be overly broad. Incorporating strategies such as facility air exchange data might better assess transmission risk.
- 27 March 2026
- Published by SAGE Publications in Public Health Reports®
Evaluation of the Newborn Metabolic Screening Form for Surveillance of Postpartum Patients for Hepatitis B Infection in New York City, 2019-2022
The New York City Department of Health and Mental Hygiene conducts surveillance of hepatitis B virus (HBV) infection among pregnant/postpartum patients. Patients are identified by multiple methods, including reporting of maternal hepatitis B surface antigen (HBsAg) status on the Newborn Metabolic Screening Form (NMSF) at the time of delivery. Health Department staff investigate reports received for HBV infection among pregnant/postpartum patients, including reports of positive HBsAg status on the NMSF, to confirm maternal HBV infection (ie, a confirmed case). We restricted this evaluation to confirmed cases that resulted in a live birth during January 2019 through June 2022 to patients with a residential address in New York City. We evaluated the utility of NMSF reports for (1) quality of demographic information, (2) the percentage of all confirmed cases that were recorded as HBsAg positive in the NMSF, (3) positive predictive value, and (4) timeliness. We received 6509 NMSF reports, of which 2575 indicated a positive HBsAg status, 1502 unknown, and 2432 missing. Among the HBsAg-positive NMSF reports, we matched 2196 to confirmed cases of HBV infection (positive predictive value, 85%). The 2196 confirmed cases with HBsAg-positive NMSF reports represented 77% of all 2864 confirmed cases of HBV infection. For 148 confirmed cases (5%), the HBsAg-positive NMSF report was the only source. Our evaluation demonstrates that the NMSF is an important supplementary reporting method for identifying pregnant/postpartum patients with HBV infection.
- 27 March 2026
- Published by SAGE Publications in Public Health Reports®
Evaluation of the Newborn Metabolic Screening Form for Surveillance of Postpartum Patients for Hepatitis B Infection in New York City, 2019-2022
The New York City Department of Health and Mental Hygiene conducts surveillance of hepatitis B virus (HBV) infection among pregnant/postpartum patients. Patients are identified by multiple methods, including reporting of maternal hepatitis B surface antigen (HBsAg) status on the Newborn Metabolic Screening Form (NMSF) at the time of delivery. Health Department staff investigate reports received for HBV infection among pregnant/postpartum patients, including reports of positive HBsAg status on the NMSF, to confirm maternal HBV infection (ie, a confirmed case). We restricted this evaluation to confirmed cases that resulted in a live birth during January 2019 through June 2022 to patients with a residential address in New York City. We evaluated the utility of NMSF reports for (1) quality of demographic information, (2) the percentage of all confirmed cases that were recorded as HBsAg positive in the NMSF, (3) positive predictive value, and (4) timeliness. We received 6509 NMSF reports, of which 2575 indicated a positive HBsAg status, 1502 unknown, and 2432 missing. Among the HBsAg-positive NMSF reports, we matched 2196 to confirmed cases of HBV infection (positive predictive value, 85%). The 2196 confirmed cases with HBsAg-positive NMSF reports represented 77% of all 2864 confirmed cases of HBV infection. For 148 confirmed cases (5%), the HBsAg-positive NMSF report was the only source. Our evaluation demonstrates that the NMSF is an important supplementary reporting method for identifying pregnant/postpartum patients with HBV infection.
- 1 April 2025
- Published by American Public Health Association in American Journal of Public Health
- Vol. 115 (4) , 575-578
Syndromic Surveillance and Case Identification for Varicella Among Recent Immigrants: New York City, 2023
Objectives. To determine utility of syndromic surveillance in improving varicella case detection during an outbreak among recent immigrants to New York City (NYC). Methods. During March through August 2023, the NYC Health Department received varicella reports from routine sources and syndromic surveillance from emergency department visits with varicella as a chief complaint or discharge diagnosis. Reports were reviewed to determine if individuals met criteria for confirmed or probable varicella cases and if cases were outbreak-associated. We calculated positive predictive value (PPV) and timeliness of syndromic surveillance reports and compared them with routine surveillance reports. Results. The health department received 639 unique varicella reports. Of 513 varicella cases, 247 (48.1%) were from syndromic surveillance alone, 194 (37.8%) from routine sources alone, and 72 (14.0%) from both sources. PPV was higher for syndromic surveillance (89.1%) versus routine surveillance (74.7%). Among 310 outbreak-associated cases, 139 were identified through syndromic surveillance (44.8%); syndromic surveillance was the only reporting source for 75 (24.2%). Syndromic surveillance was more timely than routine reporting (median = 3 days; range = 1–27 vs 5 days; range = 0–52). Conclusions. NYC syndromic surveillance improved varicella case detection during this outbreak. ( Am J Public Health. 2025;115(4):575–578. https://doi.org/10.2105/AJPH.2024.307961 )
- 1 April 2025
- Published by American Public Health Association in American Journal of Public Health
- Vol. 115 (4) , 575-578
Syndromic Surveillance and Case Identification for Varicella Among Recent Immigrants: New York City, 2023
Objectives. To determine utility of syndromic surveillance in improving varicella case detection during an outbreak among recent immigrants to New York City (NYC). Methods. During March through August 2023, the NYC Health Department received varicella reports from routine sources and syndromic surveillance from emergency department visits with varicella as a chief complaint or discharge diagnosis. Reports were reviewed to determine if individuals met criteria for confirmed or probable varicella cases and if cases were outbreak-associated. We calculated positive predictive value (PPV) and timeliness of syndromic surveillance reports and compared them with routine surveillance reports. Results. The health department received 639 unique varicella reports. Of 513 varicella cases, 247 (48.1%) were from syndromic surveillance alone, 194 (37.8%) from routine sources alone, and 72 (14.0%) from both sources. PPV was higher for syndromic surveillance (89.1%) versus routine surveillance (74.7%). Among 310 outbreak-associated cases, 139 were identified through syndromic surveillance (44.8%); syndromic surveillance was the only reporting source for 75 (24.2%). Syndromic surveillance was more timely than routine reporting (median = 3 days; range = 1–27 vs 5 days; range = 0–52). Conclusions. NYC syndromic surveillance improved varicella case detection during this outbreak. ( Am J Public Health. 2025;115(4):575–578. https://doi.org/10.2105/AJPH.2024.307961 )
- 14 August 2020
- Published by SAGE Publications in Public Health Reports®
- Vol. 135 (5) , 676-684
Trends in Hepatitis B Surveillance Among Pregnant Women in New York City, 1998-2015
Infants born to women with hepatitis B virus (HBV) infection are at high risk for chronic HBV infection and premature death. We examined epidemiologic trends among women with HBV infection who gave birth in New York City (NYC) to inform public health prevention activities. We obtained data on HBV-infected women residing and giving birth in NYC during 1998-2015 from the NYC Perinatal HBV Prevention Program. We obtained citywide birth data from the NYC Office of Vital Statistics. We calculated the incidence of births to HBV-infected women per 100 000 live births and stratified by maternal race, birthplace, and age. We calculated annual percentage change (APC) in incidence of births to HBV-infected women by using joinpoint regression. Of 29 896 HBV-infected women included in the study, 28 195 (94.3%) were non–US-born, of whom 16 600 (58.9%) were born in China. Overall incidence of births to HBV-infected women per 100 000 live births increased from 1156 in 1998 to 1573 in 2006 (APC = 3.1%; P < .001) but declined to 1329 in 2015 (APC = –1.4%; P = .02). Incidence among US-born women declined from 1998 to 2015 (330 to 84; APC = –7.3%; P < .001) and among non–US-born women increased from 1998 to 2007 (1877 to 2864; APC = 3.6%; P < .001) but not thereafter. Incidence among women born in China increased from 1998 to 2006 (13 275 to 16 480; APC = 1.8%; P = .02) but decreased to 12 631 through 2015 (APC = –3.3%; P < .001). The incidence of births to HBV-infected women in NYC declined significantly among US-born women but not among non–US-born women, highlighting the need for successful vaccination programs worldwide.
- 14 August 2020
- Published by SAGE Publications in Public Health Reports®
- Vol. 135 (5) , 676-684
Trends in Hepatitis B Surveillance Among Pregnant Women in New York City, 1998-2015
Infants born to women with hepatitis B virus (HBV) infection are at high risk for chronic HBV infection and premature death. We examined epidemiologic trends among women with HBV infection who gave birth in New York City (NYC) to inform public health prevention activities. We obtained data on HBV-infected women residing and giving birth in NYC during 1998-2015 from the NYC Perinatal HBV Prevention Program. We obtained citywide birth data from the NYC Office of Vital Statistics. We calculated the incidence of births to HBV-infected women per 100 000 live births and stratified by maternal race, birthplace, and age. We calculated annual percentage change (APC) in incidence of births to HBV-infected women by using joinpoint regression. Of 29 896 HBV-infected women included in the study, 28 195 (94.3%) were non–US-born, of whom 16 600 (58.9%) were born in China. Overall incidence of births to HBV-infected women per 100 000 live births increased from 1156 in 1998 to 1573 in 2006 (APC = 3.1%; P < .001) but declined to 1329 in 2015 (APC = –1.4%; P = .02). Incidence among US-born women declined from 1998 to 2015 (330 to 84; APC = –7.3%; P < .001) and among non–US-born women increased from 1998 to 2007 (1877 to 2864; APC = 3.6%; P < .001) but not thereafter. Incidence among women born in China increased from 1998 to 2006 (13 275 to 16 480; APC = 1.8%; P = .02) but decreased to 12 631 through 2015 (APC = –3.3%; P < .001). The incidence of births to HBV-infected women in NYC declined significantly among US-born women but not among non–US-born women, highlighting the need for successful vaccination programs worldwide.
- Open Access
- 2 January 2020
- Published by Elsevier in American Journal of Transplantation
- Vol. 20 (1) , 311-314
National update on measles cases and outbreaks — United States, January 1 – October 1, 2019
- 2 January 2020
- Published by Elsevier in American Journal of Transplantation
- Vol. 20 (1) , 311-314
Open AccessNational update on measles cases and outbreaks — United States, January 1 – October 1, 2019
- Open Access
- 1 June 2016
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 22 (6) , 1117-1119
Elevated Pertussis Reporting in Response to 2011–2012 Outbreak, New York City, New York, USA
- 1 June 2016
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 22 (6) , 1117-1119
Open AccessElevated Pertussis Reporting in Response to 2011–2012 Outbreak, New York City, New York, USA
- 13 September 2013
- Vol. 62 (36) , 752-753
Measles Outbreak Among Members of a Religious Community — Brooklyn, New York, March–June 2013
On March 13, 2013, an intentionally unvaccinated adolescent aged 17 years returned to New York City from London, United Kingdom, while infectious with measles. This importation led to the largest outbreak of measles in the United States since 1996.
- 13 September 2013
- Vol. 62 (36) , 752-753
Measles Outbreak Among Members of a Religious Community — Brooklyn, New York, March–June 2013
On March 13, 2013, an intentionally unvaccinated adolescent aged 17 years returned to New York City from London, United Kingdom, while infectious with measles. This importation led to the largest outbreak of measles in the United States since 1996.